Diabetes treatment.
Bloomgarden
Zachary T
ZT
Division of Endocrinology, Mount Sinai School of Medicine, New York, New York, USA.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists; D043562:Receptors, G-Protein-Coupled / Q000819:agonists; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D047492:Peroxisome Proliferator-Activated Receptors; D043562:Receptors, G-Protein-Coupled; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin